Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Rnf25em1flox/Cya
Common Name:
Rnf25-flox
Product ID:
S-CKO-18098
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Rnf25-flox
Strain ID
CKOCMP-57751-Rnf25-B6J-VB
Gene Name
Rnf25
Product ID
S-CKO-18098
Gene Alias
0610009H16Rik; AO7
Background
C57BL/6JCya
NCBI ID
57751
Modification
Conditional knockout
Chromosome
1
Phenotype
MGI:1890215
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Rnf25em1flox/Cya mice (Catalog S-CKO-18098) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000027357
NCBI RefSeq
NM_021313
Target Region
Exon 2~5
Size of Effective Region
~1.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Rnf25, also known as AO7, is an E3 ubiquitin ligase that plays diverse roles in multiple biological processes and disease-related pathways. It is involved in pathways such as Wnt signaling, ribosome-associated quality control, and is relevant in diseases like cancer and potentially Parkinson's disease. Genetic models, including gene knockout and conditional knockout mouse models, could be valuable in further elucidating its functions [4,2,7,6].

In cancer, loss-of-function studies have shown significant implications. Repression of Rnf25 induces E-cadherin protein expression and inhibits hepatocellular carcinoma (HCC) metastasis, indicating its role in promoting HCC metastasis through E-cadherin degradation [1]. In EGFR-mutant non-small cell lung cancer (NSCLC) cells, depletion of Rnf25 sensitizes cells to gefitinib treatment, suggesting it is essential for gefitinib resistance by mediating cross-talk between NF-κB and ERK pathways [3]. In colorectal cancer liver metastasis, circSATB1 promotes FKBP8 degradation via RNF25-mediated ubiquitination, enhancing metastatic ability [5].

In conclusion, Rnf25 is a key E3 ubiquitin ligase with essential functions in multiple biological processes, especially in cancer-related pathways. Model-based research, particularly gene knockout studies in relevant cancer models, has revealed its importance in promoting cancer metastasis and drug resistance, providing potential therapeutic targets for these diseases.

References:
1. Huang, Zhao, Zhou, Li, Duan, Jiufei, Zhang, Wei, Huang, Canhua. 2024. Oxidative Stress Promotes Liver Cancer Metastasis via RNF25-Mediated E-Cadherin Protein Degradation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2306929. doi:10.1002/advs.202306929. https://pubmed.ncbi.nlm.nih.gov/38286671/
2. Oltion, Keely, Carelli, Jordan D, Yang, Tangpo, Kampmann, Martin, Taunton, Jack. 2023. An E3 ligase network engages GCN1 to promote the degradation of translation factors on stalled ribosomes. In Cell, 186, 346-362.e17. doi:10.1016/j.cell.2022.12.025. https://pubmed.ncbi.nlm.nih.gov/36638793/
3. Cho, Jung Hee, You, Yeon-Mi, Yeom, Y I, Kim, Jung-Ae, Park, Kyung Chan. 2018. RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivation. In Cell death & disease, 9, 587. doi:10.1038/s41419-018-0651-5. https://pubmed.ncbi.nlm.nih.gov/29789542/
4. Gao, Rui, Ma, Lin-Qiang, Du, Xiaogang, Cheng, Zhi, Huang, Huizhe. . Rnf25/AO7 positively regulates wnt signaling via disrupting Nkd1-Axin inhibitory complex independent of its ubiquitin ligase activity. In Oncotarget, 7, 23850-9. doi:10.18632/oncotarget.8126. https://pubmed.ncbi.nlm.nih.gov/27007149/
5. Zhang, Chuan, Tian, Chuanxin, Zhu, Renzhong, Zhang, Yue, Sun, Yueming. 2025. CircSATB1 Promotes Colorectal Cancer Liver Metastasis through Facilitating FKBP8 Degradation via RNF25-Mediated Ubiquitination. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12, e2406962. doi:10.1002/advs.202406962. https://pubmed.ncbi.nlm.nih.gov/39921520/
6. Wettergren, Erika Elgstrand, Gussing, Fredrik, Quintino, Luis, Lundberg, Cecilia. 2012. Novel disease-specific promoters for use in gene therapy for Parkinson's disease. In Neuroscience letters, 530, 29-34. doi:10.1016/j.neulet.2012.09.059. https://pubmed.ncbi.nlm.nih.gov/23063686/
7. Gurzeler, Lukas-Adrian, Link, Marion, Ibig, Yvonne, Mühlemann, Oliver, Reinhardt, Jürgen. 2023. Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control. In Cell reports, 42, 113056. doi:10.1016/j.celrep.2023.113056. https://pubmed.ncbi.nlm.nih.gov/37651229/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest